The Need for and Impact of Rare Disease Education
February 28, 2023 | Medscape, Rare Disease Day, medical education, rare diseases
Physicians are often told that when they hear hoofbeats, think horses, not zebras — to look for the most common cause of a patient’s symptoms first. While this advice may help them through most of their interactions, there are millions of patients worldwide whose health depends on their clinicians doing the exact opposite — considering zebras, and looking for rare diseases.
While rare diseases are individually rare, they are collectively common, affecting an estimated 263 to 446 million people1 worldwide. For most, the road to diagnosis is a long one, with the mean time to diagnosis stretching to 5-7 years, but sometimes more than 10 years.2-5 Along the way, these patients may be subjected to pain, worsening of symptoms, unnecessary diagnostic tests, and ineffective treatments.
To combat the challenges faced by clinicians, more education is needed, particularly as clinicians move past medical school and residency and into practice. In a survey of almost 1000 clinicians, the prevalence of rare diseases was underestimated by 50 to 500 times as compared with current European or US prevalence definitions; and almost two-thirds of clinicians said they never or rarely see patients with rare diseases.
The data show that not only do clinicians want and need education on rare diseases, but continuing medical education (CME/CE) on Medscape.org has a significant impact on clinicians’ knowledge and competence.
Between 2018 and May 2021, more than 245,000 unique clinicians from around the world engaged in rare disease educational activities on Medscape.org. These physicians had measurable improvements in their knowledge and competence after participating in the activities, as measured by their ability to correctly answer relevant questions pre versus post education, including:
Non-physicians saw similar increases in knowledge and competence, including
Most importantly, this means that 676,000+ patient visits per year now have physicians who are better prepared to identify patients who have a rare diseases, as measured by IQVIA data.
Education is having an impact, but more is needed to fully equip clinicians with the knowledge they need. Medscape Education is committed to developing the education clinicians need and provide it in a centralized location on Medscape.org. Pathways in Rare Disease is a destination page clinicians can return to at any time for the latest education across the spectrum of rare diseases.
To learn more about Medscape Education’s rare diseases education initiatives, please contact your Medscape Representative.
- Nguengang Wakap S, Lambert DM, Olry A, et al. Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. Eur J Human Genet. 2020;28:165-173.
- Yan X, et al. Determining How far an adult rare disease patient needs to travel for a definitive diagnosis: a cross-sectional examination of the 2018 National Rare Disease Survey in China. Int J Environ Res Public Health. 2020;17:1757.
- Engel PA, et al. Physician and patient perceptions regarding physician training in rare diseases: the need for stronger educational initiatives for physicians. J Rare Disord. 2013;1:1-15.
- Global Genes. Accurate diagnosis of rare diseases remains difficult despite strong physician interest. 2014. Accessed January 18, 2023. https://globalgenes.org/2014/02/20/accurate-diagnosis-of-rare-diseases-remains-difficult-despite-strong-physician-interest-2/
- Marwaha S, et al. A guide for the diagnosis of rare and undiagnosed disease: beyond the exome. Genome Med. 2022;14:23.
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
The Heart and Mouth Connection Every Woman Needs to Know
For decades, modern medicine has treated the mouth and the body as separate entities. But for Dr. Nieca Goldberg, a renowned cardiologist, and Dr. Maria Ryan, Chief Clinical Officer at...
Uncovering Inequities in Alzheimer’s Disease Screening and Care
On December 5, MAPS hosted an educational webinar exploring recent research in Alzheimer’s disease (AD) screening, testing, and treatment. Experts from Komodo Health and Medscape shared findings from their...
Where Are We Today With Artificial Intelligence (AI) in Rare Disease Diagnosis and Care?
Discover how AI-powered tools are transforming rare disease diagnosis, patient care, and clinical decision-making.
Does Rare Disease Education Work?
For a child with a rare disease, a doctor’s continuing education can end a years-long diagnostic odyssey and unlock access to vital care.
From Genetic Puzzles to Precision Therapeutics
How was a new rare disease discovered through Singapore’s Undiagnosed Disease Program? And how will technology allow us to change how we discover rare diseases in the future? Read more...
Medscape and the GNNRD: Empowering Nurses With a Rare Disease Education Series
Nurses play a vital and multifaceted role in rare disease care, providing consistent patient support, education, and care coordination, and ongoing education is essential to empower them to meet the...
What Is the RDI-Lancet Commission for Rare Disease and What Will It Achieve?
Christy Rohani-Montez, Medscape’s Rare Disease Education Lead recently spoke with Dr Lucy McKay, CEO, and Megan Pullein, Strategic Operations Officer from the UK-based charity Medics for Rare Disease (MfRD). We...
“CGM Sweet Talk With the Sugar Queens” Takes Silver at the 2025 Digital Health Awards
Medscape Education’s dynamic educational series, CGM Sweet Talk With the Sugar Queens, has earned a Silver Award in the Video Series (Digital Health Media / Publications) category at the 2025...
Medscape at ASH 2025: Landmark Value Through the Medscape AI Debut and Five Educational Symposia
For decades, Medscape has been the brand physicians trust. Now, Medscape is forging a new path into the future at ASH 2025 with the launch of Medscape AI — the...
Women Leaders Rewriting the Protocols of Rare Disease Care
The true measure of a medical leader is the courage to act when existing systems fail the patient. This is the professional and personal ethos of clinical immunologist Dr. Hilary...